Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction

Journal of the American College of Cardiology

Volumn 29, Issue 7, 1997, Pages 1468-1473

  Dakik, Habib A ^a   Mahmarian, John J ^a   Verani, Mario S ^a   Farmer, John A ^a   Zhao, Guiling ^a   Marian, Ali J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALLIUM 201;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RESPONSE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE INSERTION; GENETIC PREDISPOSITION; GENOTYPE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADENOSINE; CARDIOVASCULAR AGENTS; CORONARY VESSELS; FEMALE; GENE DELETION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RADIONUCLIDE ANGIOGRAPHY; THALLIUM RADIOISOTOPES; VASCULAR PATENCY;

EID: 0030955439     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00086-7     Document Type: Article

References (36)

1. Griendling KK, Murphy TJ, Wayne Alexander R. Molecular biology of the renin-angiotensin system. Circulation. 87:1993;1816-1828.
2. Sadoshima J-I, Izumo S. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts critical role of the AT1 receptor subtype . Circ Res. 73:1993;413-423.
3. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol. 35:1995;679-705.
4. Hubert C, Houot A-M, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene two alternate promoters correspond to evolutionary steps of a duplicated gene . J Biol Chem. 266:1991;15377-15383.
5. Soubrier F, Alhenc-Gelas F, Hubert C, et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 85:1988;9386-9390.
6. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 92:1995;3105-3112.
7. Passier RC, Smits JF, Weruyten MJ, Studer R, Drexler H, Daemen MJ. Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol. 269:1995;H1268-H1276.
8. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell B. Increased rat cardiac angiotensin converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy. Circulation. 87:1993;1328-1339.
9. Hokimoto S, Yasue H, Fujimoto K, et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation. 94:1996;1513-1518.
10. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
11. Pfeffer MA, Braunwald E. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 327:1992;669-677.
12. Pfeffer MA, Lamas GA, Vaughan DE, Paris AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
13. Linz W, Schaper J, Wiemer G, Albus U, Scholkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction a one year study in rats . Br J Pharmacol. 107:1992;970-975.
14. Sharpe N. The effects of angiotensin-1 converting enzyme inhibition on progression of atherosclerosis. J Cardiovasc Pharmacol. 22:(Suppl 9):1993;S9-12.
15. Tiret L, Rigat B, Visvikis S, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma angiotensin-1 converting enzyme levels. Am J Hum Genet. 51:1992;197-205.
16. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corval P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
17. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 90:1994;669-676.
18. Danser AHJ, Schalekamp MADH, Bax WA, et al. Angiotensin-converting enzyme in the human heart effect of the deletion/insertion polymorphism . Circulation. 92:1995;1387-1388.
19. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
20. Beohar N, Prather A, Yu Q-T, et al. Angiotensin converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med. 43:1995;275-280.
21. Ruiz J, Blache H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary artery disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 91:1994;3662-3665.
22. Marian AJ, Yu Q-T, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism is associated with hypertrophic cardiomyopathy as well as sudden cardiac death. Lancet. 342:1993;1073-1074.
23. Pinto YM, van Gilst WH, Kingma JH, Schunkert H. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilatation after anterior myocardial infarction. J Am Coll Cardiol. 25:1995;1622-1626.
24. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M. The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol. 76:1995;326-329.
25. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) trial, phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge . Circulation. 76:1987;142-154.
26. Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS. Role of adenosine thallium-201 tomography for defining long-term risk in patients after myocardial infarction. J Am Coll Cardiol. 25:1995;1333-1340.
27. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
28. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:1992;1433.
29. Yusuf S, Pepine CJ, Gares C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 340:1992;1173-1178.
30. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 90:1994;2056-2069.
31. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 (PAI-1) in cultured endothelial cells a potential link between the renin-angiotensin system and thrombosis . J Clin Invest. 95:1995;995-1001.
32. James IM, Dickenson EJ, Burgoyne W, et al. Treatment of hypertension with captopril preservation of regional blood flow and reduced platelet aggregation . J Hum Hypertens. 2:1988;21-25.
33. Someya N, Morotomi Y, Kodama K, et al. Suppressive effect of captopril on platelet aggregation in essential hypertension. J Cardiovasc Pharmacol. 6:1984;840-843.
34. Lechin M, Quinones M, Omran A, et al. Angiotensin 1 converting enzyme genotypes influence the phenotypic expression of hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
35. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
36. Krege JH, John SWM, Langenbach LL, et al. Male-female differences in fertility and blood pressure in angiotensin-1 converting enzyme-deficient mice. Nature. 375:1995;146-148.